MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

MDT

85.26

-0.95%↓

A

120.85

-0.66%↓

VEEV

168.97

+0.64%↑

HQY

86.11

+0.21%↑

NEOG

9.63

+1.37%↑

Search

Evolent Health Inc

Geschlossen

BrancheGesundheitswesen

2.92 2.46

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.81

Max

2.93

Schlüsselkennzahlen

By Trading Economics

Einkommen

-408M

-429M

Verkäufe

-11M

469M

Gewinnspanne

-91.554

Angestellte

4,200

EBITDA

-374M

-360M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+80.99% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

7. Mai 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-39M

282M

Vorheriger Eröffnungskurs

0.46

Vorheriger Schlusskurs

2.92

Nachrichtenstimmung

By Acuity

50%

50%

159 / 348 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

Evolent Health Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

20. Apr. 2026, 23:49 UTC

Wichtige Nachrichtenereignisse

New Zealand 1Q Inflation Higher Than Expected

20. Apr. 2026, 23:10 UTC

Heiße Aktien

Stocks to Watch: Amazon, Alaska Air Group, BridgeBio Oncology, AXT

20. Apr. 2026, 22:53 UTC

Wichtige Markttreiber

BridgeBio Oncology Shares Rise After FDA Fast-Tracks Pancreatic Cancer Treatment

20. Apr. 2026, 23:45 UTC

Market Talk

Nikkei May Rise on Hopes for U.S.-Iran Peace Talks -- Market Talk

20. Apr. 2026, 23:44 UTC

Market Talk

Gold Consolidates as End of Cease-Fire Looms -- Market Talk

20. Apr. 2026, 23:39 UTC

Market Talk

Rio Tinto Posts Strong Start to Year -- Market Talk

20. Apr. 2026, 23:30 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

20. Apr. 2026, 23:30 UTC

Market Talk

Global Equities Roundup: Market Talk

20. Apr. 2026, 23:30 UTC

Market Talk

Super Retail's Earnings Outlook Less Rosy -- Market Talk

20. Apr. 2026, 23:09 UTC

Market Talk

Viva Energy's Refinery Fire More Benign Than Jefferies Thought -- Market Talk

20. Apr. 2026, 22:31 UTC

Akquisitionen, Fusionen, Übernahmen

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20. Apr. 2026, 22:26 UTC

Akquisitionen, Fusionen, Übernahmen

West African Resources Says Sanbrado, Toega Operations Not Subject to Govt Request for Additional Participation

20. Apr. 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

West African Resources Plans to Distribute Cash Proceeds to Shareholders Via Special Dividend

20. Apr. 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

West African Resources Aims for Acquisition to Be Completed by End-2026

20. Apr. 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

West African Resources Says to Work Cooperatively With Govt to Finalize Deal Terms

20. Apr. 2026, 22:25 UTC

Akquisitionen, Fusionen, Übernahmen

West African Resources Says Acquisition Would Be for A$175 Million

20. Apr. 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

West African Resources Says Burkina Faso Govt Issues Decree to Acquire 25% of Kiaka

20. Apr. 2026, 22:15 UTC

Akquisitionen, Fusionen, Übernahmen

Anthropic, Amazon Tighten Bond in $5 Billion Investment and Computing Deal -- WSJ

20. Apr. 2026, 22:01 UTC

Akquisitionen, Fusionen, Übernahmen

Amazon Invests $5B in Anthropic Amid Expanded Collaboration

20. Apr. 2026, 21:38 UTC

Market Talk

Apple's New CEO Will Face Immediate Pressure on AI Strategy -- Market Talk

20. Apr. 2026, 21:33 UTC

Akquisitionen, Fusionen, Übernahmen

Uber Expands Stake In Lucid for Robo-Taxis. This Is How Tesla's Stock Is Responding. -- Barrons.com

20. Apr. 2026, 21:24 UTC

Market Talk

Apple's CEO Change Timing Will Garner Mixed Reaction, Analyst Says -- Market Talk

20. Apr. 2026, 21:24 UTC

Market Talk

Global Equities Roundup: Market Talk

20. Apr. 2026, 21:13 UTC

Ergebnisse

Alaska Air: Expansion of Card Portfolio Expected to Accelerate Loyalty Platform Beyond Incremental $150M Profit Outlined in Alaska Accelerate Strategy

20. Apr. 2026, 21:10 UTC

Ergebnisse

Alaska Air to Move Toward a Single Issuer for Atmos Rewards Credit Cards

20. Apr. 2026, 21:09 UTC

Ergebnisse

Alaska Air Sees 2Q Capacity Up About 1% Year-Over-Year, Down Nearly a Point From Original Views, on 'Proactive Trimming' of May and June Capacity

20. Apr. 2026, 21:08 UTC

Ergebnisse

Alaska Air 'Continues to Operate From a Position of Strength,' With Healthy Balance Sheet, Strong Liquidity, About $20B in Unencumbered Assets

20. Apr. 2026, 21:07 UTC

Ergebnisse

Alaska Air: Taken Together, Rev, Cost and Fuel Assumptions Result in 2Q Adjusted Loss Per Share Estimate of About $1

20. Apr. 2026, 21:05 UTC

Ergebnisse

Alaska Air: This Assumption Adds About $600M of Expense to 2Q, Equivalent to EPS Headwind of $3.60

20. Apr. 2026, 21:05 UTC

Ergebnisse

Alaska Air Expects 2Q Fuel Cost to Average About $4.50 Based on Forward Curve Today

Peer-Vergleich

Kursveränderung

Evolent Health Inc Prognose

Kursziel

By TipRanks

80.99% Vorteil

12-Monats-Prognose

Durchschnitt 5.14 USD  80.99%

Hoch 8 USD

Tief 3 USD

Basierend auf 14 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Evolent Health Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

14 ratings

12

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

10.33 / 10.95Unterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Very Strong Bullish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

159 / 348 Ranking in Gesundheitswesen

Nachrichtenstimmung

Neutral

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Evolent Health Inc

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.
help-icon Live chat